Topical Administration of Mometasone Is Not Helpful in Post-COVID-19 Olfactory Dysfunction

URN to cite this document:: urn:nbn:de:bvb:355-epub-529422
DOI to cite this document:: 10.5283/epub.52942

Hintschich, Constantin A.

; Dietz, Melanie ; Haehner, Antje ; Hummel, Thomas

License: Creative Commons Attribution 4.0
PDF - Published Version
(599kB)

Date of publication of this fulltext: 28 Sep 2022 08:31

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Persistent olfactory dysfunction is a major concern post-COVID-19, affecting up to 5% of all patients. Different therapeutic options, including mometasone nasal spray, have been recommended, only some of which have been validated for post-COVID-19 olfactory dysfunction. In this study we psychophysically assessed the effect of intranasally applied mometasone furoate on the recovery of olfaction. ...